Jason Meyenburg

Jason Meyenburg is the founder of Gemini Therapeutics. Gemini Therapeutics has raised $216M in total funding. Latest round: IPO.

About Jason Meyenburg

Jason Meyenburg was the Chief Executive Officer of Gemini Therapeutics, a precision medicine company focused on age-related macular degeneration. The company went public on the Nasdaq Exchange in February 2021 through a merger with FS Development Corp., a SPAC sponsored by Foresite Capital.

Jason Meyenburg at a glance

More founders in Cambridge, MA, United States (44)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library